Solesence, Inc. (SLSN) stock
SLSNNasdaqPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 17/3023% below fair value
$1.52+0.61 (+67.22%)
Close on Nov 13, 2026Market cap $107.38MP/E 38.0Yield –
Solesence ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Solesence's ebitda for the twelve months ending Sep 30, 2026 was $4.85M, up 205.3% year over year. For fiscal 2025 it was $3.49M, up 19.3% from the year before. The highest annual figure on record is $3.49M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.49M | +19.3% |
| FY2024 | Dec 31, 2024 | $2.92M | – |
| FY2023 | Dec 31, 2023 | -$3.35M | – |
| FY2022 | Dec 31, 2022 | -$1.69M | -156.1% |
| FY2021 | Dec 31, 2021 | $3.01M | +63.5% |
| FY2020 | Dec 31, 2020 | $1.84M | – |
| FY2019 | Dec 31, 2019 | -$2.48M | – |
| FY2018 | Dec 31, 2018 | -$1.70M | – |
| FY2017 | Dec 31, 2017 | -$428.00K | – |
| FY2016 | Dec 31, 2016 | -$658.00K | – |
| FY2015 | Dec 31, 2015 | -$443.00K | – |
| FY2014 | Dec 31, 2014 | -$980.00K | – |
| FY2013 | Dec 31, 2013 | -$1.62M | – |
| FY2012 | Dec 31, 2012 | -$1.41M | – |
| FY2011 | Dec 31, 2011 | -$2.24M | – |
| FY2010 | Dec 31, 2010 | -$2.95M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $4.35M | – |
| Q2 FY2026 | Jun 30, 2026 | $346.00K | -87.6% |
| Q1 FY2026 | Mar 31, 2026 | -$361.00K | -157.0% |
| Q4 FY2025 | Dec 31, 2025 | $517.00K | – |
| Q3 FY2025 | Sep 30, 2025 | -$452.00K | -114.6% |
| Q2 FY2025 | Jun 30, 2025 | $2.79M | +117.6% |
| Q1 FY2025 | Mar 31, 2025 | $633.00K | -52.9% |
| Q4 FY2024 | Dec 31, 2024 | -$1.38M | – |
| Q3 FY2024 | Sep 30, 2024 | $3.10M | – |
| Q2 FY2024 | Jun 30, 2024 | $1.28M | +70.7% |
| Q1 FY2024 | Mar 31, 2024 | $1.35M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.23M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.04M | – |
| Q2 FY2023 | Jun 30, 2023 | $751.00K | +191.1% |
| Q1 FY2023 | Mar 31, 2023 | -$830.00K | -444.4% |
| Q4 FY2022 | Dec 31, 2022 | -$1.70M | – |
| Q3 FY2022 | Sep 30, 2022 | -$492.00K | -132.4% |
| Q2 FY2022 | Jun 30, 2022 | $258.00K | -75.9% |
| Q1 FY2022 | Mar 31, 2022 | $241.00K | -59.7% |
| Q4 FY2021 | Dec 31, 2021 | -$173.00K | -141.7% |
| Q3 FY2021 | Sep 30, 2021 | $1.52M | +137.0% |
| Q2 FY2021 | Jun 30, 2021 | $1.07M | +43.7% |
| Q1 FY2021 | Mar 31, 2021 | $598.00K | +1290.7% |
| Q4 FY2020 | Dec 31, 2020 | $415.00K | – |
| Q3 FY2020 | Sep 30, 2020 | $641.00K | – |
| Q2 FY2020 | Jun 30, 2020 | $744.00K | – |
| Q1 FY2020 | Mar 31, 2020 | $43.00K | – |
| Q4 FY2019 | Dec 31, 2019 | -$833.00K | – |
| Q3 FY2019 | Sep 30, 2019 | -$736.00K | – |
| Q2 FY2019 | Jun 30, 2019 | -$519.00K | -391.6% |
| Q1 FY2019 | Mar 31, 2019 | -$393.00K | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.00M | – |
| Q3 FY2018 | Sep 30, 2018 | -$51.00K | – |
| Q2 FY2018 | Jun 30, 2018 | $178.00K | +54.8% |
| Q1 FY2018 | Mar 31, 2018 | -$828.00K | -641.2% |
| Q4 FY2017 | Dec 31, 2017 | -$146.00K | – |
| Q3 FY2017 | Sep 30, 2017 | -$550.00K | – |
| Q2 FY2017 | Jun 30, 2017 | $115.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $153.00K | – |
| Q4 FY2016 | Dec 31, 2016 | -$601.00K | – |
See a number that looks wrong?